InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

HALOZYME THERAPEUTICS, INC.

HALO Clue Score50
United States Fiscal year ends December CIK 0001159036 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Matthew L. Posard
14 Aug 2024
Director
Sell
9,881
$57.70
$570.13K
Matthew L. Posard
13 Aug 2024
Director
Sell
10,000
$56.19
$561.93K
Matthew L. Posard
12 Aug 2024
Director
Sell
10,000
$55.72
$557.23K
Matthew L. Posard
12 Jun 2024
Director
Sell
10,000
$50.62
$506.19K
Matthew L. Posard
11 Jun 2024
Director
Sell
10,000
$50.01
$500.11K
James M Daly
14 Aug 2023
Director
Sell
10,000
$43.74
$437.41K
James M Daly
11 Aug 2023
Director
Sell
10,000
$43.71
$437.11K
Jeffrey William Henderson
1 Mar 2023
Director
Sell
10,000
$47.71
$477.10K
Jeffrey William Henderson
28 Feb 2023
Director
Sell
10,000
$48.51
$485.10K
Michael J. LaBarre
27 Feb 2023
SVP, Chief Technical Officer
Sell
2,984
$49.55
$147.85K
Michael J. LaBarre
27 Feb 2023
SVP, Chief Technical Officer
Sell
7,016
$49.55
$347.63K
Showing 250 of 385 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 371
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 38
Sales straight out of an exercise 246
Sales at will 88
Transactions with no price 0
Shares from compensation/vesting 16,897,288
Sales filed before the plan box existed 81
History held since 6 Dec 2006